new_0222_0379|GLUE|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0379|GLUE|1|Monte Rosa Therapeutics Inc PS Ratio|Monte Rosa Therapeutics Inc Price to Book Value|Monte Rosa Therapeutics Inc PEG Ratio|Monte Rosa Therapeutics Inc Price (USD)|Monte Rosa Therapeutics Inc Short Interest|Monte Rosa Therapeutics Inc Dividend Yield|Monte Rosa Therapeutics Inc Earnings Yield|Monte Rosa Therapeutics Inc Market Cap (USD)|Monte Rosa Therapeutics Inc PE Ratio|Monte Rosa Therapeutics Inc Consensus Recommendation|Monte Rosa Therapeutics Inc Price Target Num Estimates|Monte Rosa Therapeutics Inc Price Target (USD)|Monte Rosa Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Monte Rosa Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Monte Rosa Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Monte Rosa Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Monte Rosa Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Monte Rosa Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Monte Rosa Therapeutics Inc Revenue (Quarterly) (USD)|Monte Rosa Therapeutics Inc EBITDA (Quarterly) (USD)|Monte Rosa Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0379|GLUE|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0379|GLUE|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0379|GLUE|5||1.43827160494||1.43975903614|15.3571428571|1.43975903614|1.43975903614|1.43975903614||13.6666666667|25.625|25.625|29.2857142857|25.625|25.625|22.7777777778|121|121||91.3333333333|91.3333333333||
new_0222_0379|GLUE|6||162||166|14|166|166|166||15|8|8|7|8|8|9|1|1||6|6||
new_0222_0379|GLUE|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0379|GLUE|20200315||||||||||||||||||||-4.228|-4.302||
new_0222_0379|GLUE|20200615||||||||||||||||||||-5.324|-5.364||
new_0222_0379|GLUE|20200915||||||||||||||||||||-6.215|-6.558||
new_0222_0379|GLUE|20201215||||||||||||||||||||-11.713|-19.656||
new_0222_0379|GLUE|20210315||||||||||||||||||||-11.23|-12.276||
new_0222_0379|GLUE|20210615||2.8387||21.18|737322||-9.5027|942.3024||||||||||||-17.656|-18.405|18.86|22.7
new_0222_0379|GLUE|20210715||2.7812||22.24|659973||-24.2622|991.9863||1.5|3|36|||-1.9384|-1.737|-62.6098|-87.8505||||22.23|24.52
new_0222_0379|GLUE|20210815||3.2101||25.67|1186637||-21.0203|1144.977||1.5|3|39.3333|||-2.0533|-5.1733||||||27.62|35.69
new_0222_0379|GLUE|20210915||4.909||37.75|1938568||-14.2938|1750.9167||1.5||||||||||-19.286|-19.837|41.1|22.28
new_0222_0379|GLUE|20211015||2.5262||20.07|2398922||-27.5248|932.9319||1.5|3|39.3333|||-2.0551|-4.6792||||||19.12|23.45
new_0222_0379|GLUE|20211115||3.0196||23.99|2531434||-23.0272|1115.1488||1.8|4|34.5|||-2.0676|-5.27|-69|-92||||25.89|19.39
new_0222_0379|GLUE|20211215||2.1924||17.41|3231481||-31.7302|809.6677||||||||-3.8423||||||17.12|20.42
new_0222_0379|GLUE|20220115||2.5702||20.41|3516705||-27.0663|949.1854||1.6667|5|33||||||||||20.2|12.66
new_0222_0379|GLUE|20220215||1.6698||13.26|||-41.6609|616.6682||1.6667|5|32|||-2.5425|-2.1263||||||13.27|13.6